Control of alveolar differentiation by the lineage transcription factors GATA6 and HOPX inhibits lung adenocarcinoma metastasis

Cancer Cell

Volumn 23, Issue 6, 2013, Pages 725-738

  Cheung, WilliamK C ^a   Zhao, Minghui ^a   Liu, Zongzhi ^a   Stevens, LauraE ^a   Cao, PaulD ^a   Fang, JustinE ^c   Westbrook, ThomasF ^c   Nguyen, DonX ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE CANCER CENTER   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 6; TRANSCRIPTION FACTOR HOPX; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CELL DIFFERENTIATION; CELL LINEAGE; CELL SURVIVAL; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; LUNG ALVEOLUS; METASTASIS; METASTASIS INHIBITION; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RESPIRATORY EPITHELIUM;

EID: 84878990582     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccr.2013.04.009     Document Type: Article

References (68)

1. Alam N., Gustafson K.S., Ladanyi M., Zakowski M.F., Kapoor A., Truskinovsky A.M., Dudek A.Z. Small-cell carcinoma with an epidermal growth factor receptor mutation in a never-smoker with gefitinib-responsive adenocarcinoma of the lung. Clin. Lung Cancer 2010, 11:E1-E4.
2. Ballard P.L., Lee J.W., Fang X., Chapin C., Allen L., Segal M.R., Fischer H., Illek B., Gonzales L.W., Kolla V., Matthay M.A. Regulated gene expression in cultured type II cells of adult human lung. Am. J. Physiol. Lung Cell. Mol. Physiol. 2010, 299:L36-L50.
3. Barletta J.A., Perner S., Iafrate A.J., Yeap B.Y., Weir B.A., Johnson L.A., Johnson B.E., Meyerson M., Rubin M.A., Travis W.D., et al. Clinical significance of TTF-1 protein expression and TTF-1 gene amplification in lung adenocarcinoma. J. Cell. Mol. Med. 2009, 13(8B):1977-1986.
4. Belaguli N.S., Aftab M., Rigi M., Zhang M., Albo D., Berger D.H. GATA6 promotes colon cancer cell invasion by regulating urokinase plasminogen activator gene expression. Neoplasia 2010, 12:856-865.
5. Ben-Porath I., Thomson M.W., Carey V.J., Ge R., Bell G.W., Regev A., Weinberg R.A. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat. Genet. 2008, 40:499-507.
6. Bhattacharjee A., Richards W.G., Staunton J., Li C., Monti S., Vasa P., Ladd C., Beheshti J., Bueno R., Gillette M., et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc. Natl. Acad. Sci. USA 2001, 98:13790-13795.
7. Blanco M.A., LeRoy G., Khan Z., Alečković M., Zee B.M., Garcia B.A., Kang Y. Global secretome analysis identifies novel mediators of bone metastasis. Cell Res. 2012, 22:1339-1355.
8. Bos P.D., Zhang X.H., Nadal C., Shu W., Gomis R.R., Nguyen D.X., Minn A.J., van de Vijver M.J., Gerald W.L., Foekens J.A., Massagué J. Genes that mediate breast cancer metastasis to the brain. Nature 2009, 459:1005-1009.
9. Cai K.Q., Caslini C., Capo-chichi C.D., Slater C., Smith E.R., Wu H., Klein-Szanto A.J., Godwin A.K., Xu X.X. Loss of GATA4 and GATA6 expression specifies ovarian cancer histological subtypes and precedes neoplastic transformation of ovarian surface epithelia. PLoS ONE 2009, 4:e6454.
10. Carretero J., Shimamura T., Rikova K., Jackson A.L., Wilkerson M.D., Borgman C.L., Buttarazzi M.S., Sanofsky B.A., McNamara K.L., Brandstetter K.A., et al. Integrative genomic and proteomic analyses identify targets for Lkb1-deficient metastatic lung tumors. Cancer Cell 2010, 17:547-559.
11. Chen F., Kook H., Milewski R., Gitler A.D., Lu M.M., Li J., Nazarian R., Schnepp R., Jen K., Biben C., et al. Hop is an unusual homeobox gene that modulates cardiac development. Cell 2002, 110:713-723.
12. Chen Y., Pacyna-Gengelbach M., Deutschmann N., Niesporek S., Petersen I. Homeobox gene HOP has a potential tumor suppressive activity in human lung cancer. Int. J. Cancer 2007, 121:1021-1027.
13. Clevers H. Wnt/beta-catenin signaling in development and disease. Cell 2006, 127:469-480.
14. Collisson E.A., Sadanandam A., Olson P., Gibb W.J., Truitt M., Gu S., Cooc J., Weinkle J., Kim G.E., Jakkula L., et al. Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy. Nat. Med. 2011, 17:500-503.
15. Eramo A., Haas T.L., De Maria R. Lung cancer stem cells: tools and targets to fight lung cancer. Oncogene 2010, 29:4625-4635.
16. Feldman S.A., Eiden L.E. The chromogranins: their roles in secretion from neuroendocrine cells and as markers for neuroendocrine neoplasia. Endocr. Pathol. 2003, 14:3-23.
17. Gabrielson E. Worldwide trends in lung cancer pathology. Respirology 2006, 11:533-538.
18. Garraway L.A., Sellers W.R. Lineage dependency and lineage-survival oncogenes in human cancer. Nat. Rev. Cancer 2006, 6:593-602.
19. Gerson K.D., Foster C.D., Zhang P., Zhang Z., Rosenblatt M.M., Guttentag S.H. Pepsinogen C proteolytic processing of surfactant protein B. J. Biol. Chem. 2008, 283:10330-10338.
20. Glatt S., Halbauer D., Heindl S., Wernitznig A., Kozina D., Su K.C., Puri C., Garin-Chesa P., Sommergruber W. hGPR87 contributes to viability of human tumor cells. Int. J. Cancer 2008, 122:2008-2016.
21. Gomes I.M., Maia C.J., Santos C.R. STEAP proteins: from structure to applications in cancer therapy. Mol. Cancer Res. 2012, 10:573-587.
22. Gonzales L.W., Guttentag S.H., Wade K.C., Postle A.D., Ballard P.L. Differentiation of human pulmonary type II cells invitro by glucocorticoid plus cAMP. Am. J. Physiol. Lung Cell. Mol. Physiol. 2002, 283:L940-L951.
23. Gupta G.P., Nguyen D.X., Chiang A.C., Bos P.D., Kim J.Y., Nadal C., Gomis R.R., Manova-Todorova K., Massagué J. Mediators of vascular remodelling co-opted for sequential steps in lung metastasis. Nature 2007, 446:765-770.
24. Hecht J.L., Pinkus J.L., Weinstein L.J., Pinkus G.S. The value of thyroid transcription factor-1 in cytologic preparations as a marker for metastatic adenocarcinoma of lung origin. Am. J. Clin. Pathol. 2001, 116:483-488.
25. Jemal A., Thun M.J., Ries L.A., Howe H.L., Weir H.K., Center M.M., Ward E., Wu X.C., Eheman C., Anderson R., et al. Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. J. Natl. Cancer Inst. 2008, 100:1672-1694.
26. Kang Y., Siegel P.M., Shu W., Drobnjak M., Kakonen S.M., Cordón-Cardo C., Guise T.A., Massagué J. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 2003, 3:537-549.
27. Keijzer R., van Tuyl M., Meijers C., Post M., Tibboel D., Grosveld F., Koutsourakis M. The transcription factor GATA6 is essential for branching morphogenesis and epithelial cell differentiation during fetal pulmonary development. Development 2001, 128:503-511.
28. Kenny P.A., Lee G.Y., Myers C.A., Neve R.M., Semeiks J.R., Spellman P.T., Lorenz K., Lee E.H., Barcellos-Hoff M.H., Petersen O.W., et al. The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression. Mol. Oncol. 2007, 1:84-96.
29. Kouros-Mehr H., Bechis S.K., Slorach E.M., Littlepage L.E., Egeblad M., Ewald A.J., Pai S.Y., Ho I.C., Werb Z. GATA-3 links tumor differentiation and dissemination in a luminal breast cancer model. Cancer Cell 2008, 13:141-152.
30. Kumar P.A., Hu Y., Yamamoto Y., Hoe N.B., Wei T.S., Mu D., Sun Y., Joo L.S., Dagher R., Zielonka E.M., et al. Distal airway stem cells yield alveoli invitro and during lung regeneration following H1N1 influenza infection. Cell 2011, 147:525-538.
31. Kumar M.S., Hancock D.C., Molina-Arcas M., Steckel M., East P., Diefenbacher M., Armenteros-Monterroso E., Lassailly F., Matthews N., Nye E., et al. The GATA2 transcriptional network is requisite for RAS oncogene-driven non-small cell lung cancer. Cell 2012, 149:642-655.
32. Lin L., Bass A.J., Lockwood W.W., Wang Z., Silvers A.L., Thomas D.G., Chang A.C., Lin J., Orringer M.B., Li W., et al. Activation of GATA binding protein 6 (GATA6) sustains oncogenic lineage-survival in esophageal adenocarcinoma. Proc. Natl. Acad. Sci. USA 2012, 109:4251-4256.
33. Lindholm P.M., Soini Y., Myllärniemi M., Knuutila S., Heikinheimo M., Kinnula V.L., Salmenkivi K. Expression of GATA-6 transcription factor in pleural malignant mesothelioma and metastatic pulmonary adenocarcinoma. J. Clin. Pathol. 2009, 62:339-344.
34. Liu C., Morrisey E.E., Whitsett J.A. GATA-6 is required for maturation of the lung in late gestation. Am. J. Physiol. Lung Cell. Mol. Physiol. 2002, 283:L468-L475.
35. Liu C., Glasser S.W., Wan H., Whitsett J.A. GATA-6 and thyroid transcription factor-1 directly interact and regulate surfactant protein-C gene expression. J. Biol. Chem. 2002, 277:4519-4525.
36. Maeda Y., Davé V., Whitsett J.A. Transcriptional control of lung morphogenesis. Physiol. Rev. 2007, 87:219-244.
37. Maeda Y., Tsuchiya T., Hao H., Tompkins D.H., Xu Y., Mucenski M.L., Du L., Keiser A.R., Fukazawa T., Naomoto Y., et al. Kras(G12D) and Nkx2-1 haploinsufficiency induce mucinous adenocarcinoma of the lung. J. Clin. Invest. 2012, 122:4388-4400.
38. Molkentin J.D. The zinc finger-containing transcription factors GATA-4, -5, and -6. Ubiquitously expressed regulators of tissue-specific gene expression. J. Biol. Chem. 2000, 275:38949-38952.
39. Moll R., Franke W.W., Schiller D.L., Geiger B., Krepler R. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982, 31:11-24.
40. Morrisey E.E., Hogan B.L. Preparing for the first breath: genetic and cellular mechanisms in lung development. Dev. Cell 2010, 18:8-23.
41. Morrisey E.E., Ip H.S., Lu M.M., Parmacek M.S. GATA-6: a zinc finger transcription factor that is expressed in multiple cell lineages derived from lateral mesoderm. Dev. Biol. 1996, 177:309-322.
42. Nguyen D.X., Chiang A.C., Zhang X.H., Kim J.Y., Kris M.G., Ladanyi M., Gerald W.L., Massagué J. WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis. Cell 2009, 138:51-62.
43. Ooki A., Yamashita K., Kikuchi S., Sakuramoto S., Katada N., Kokubo K., Kobayashi H., Kim M.S., Sidransky D., Watanabe M. Potential utility of HOP homeobox gene promoter methylation as a marker of tumor aggressiveness in gastric cancer. Oncogene 2010, 29:3263-3275.
44. Pacheco-Pinedo E.C., Durham A.C., Stewart K.M., Goss A.M., Lu M.M., Demayo F.J., Morrisey E.E. Wnt/β-catenin signaling accelerates mouse lung tumorigenesis by imposing an embryonic distal progenitor phenotype on lung epithelium. J. Clin. Invest. 2011, 121:1935-1945.
45. Rawlins E.L., Clark C.P., Xue Y., Hogan B.L. The Id2+ distal tip lung epithelium contains individual multipotent embryonic progenitor cells. Development 2009, 136:3741-3745.
46. Rhodes D.R., Kalyana-Sundaram S., Mahavisno V., Barrette T.R., Ghosh D., Chinnaiyan A.M. Mining for regulatory programs in the cancer transcriptome. Nat. Genet. 2005, 37:579-583.
47. Roman J., Ritzenthaler J.D., Roser-Page S., Sun X., Han S. alpha5beta1-integrin expression is essential for tumor progression in experimental lung cancer. Am. J. Respir. Cell Mol. Biol. 2010, 43:684-691.
48. Rothenberg S.M., Engelman J.A., Le S., Riese D.J., Haber D.A., Settleman J. Modeling oncogene addiction using RNA interference. Proc. Natl. Acad. Sci. USA 2008, 105:12480-12484.
49. Saito R.A., Watabe T., Horiguchi K., Kohyama T., Saitoh M., Nagase T., Miyazono K. Thyroid transcription factor-1 inhibits transforming growth factor-beta-mediated epithelial-to-mesenchymal transition in lung adenocarcinoma cells. Cancer Res. 2009, 69:2783-2791.
50. Shin C.H., Liu Z.P., Passier R., Zhang C.L., Wang D.Z., Harris T.M., Yamagishi H., Richardson J.A., Childs G., Olson E.N. Modulation of cardiac growth and development by HOP, an unusual homeodomain protein. Cell 2002, 110:725-735.
51. Singh A., Greninger P., Rhodes D., Koopman L., Violette S., Bardeesy N., Settleman J. A gene expression signature associated with "K-Ras addiction" reveals regulators of EMT and tumor cell survival. Cancer Cell 2009, 15:489-500.
52. Sinha S., Adler A.S., Field Y., Chang H.Y., Segal E. Systematic functional characterization of cis-regulatory motifs in human core promoters. Genome Res. 2008, 18:477-488.
53. Snyder E.L., Watanabe H., Magendantz M., Hoersch S., Chen T.A., Wang D.G., Crowley D., Whittaker C.A., Meyerson M., Kimura S., Jacks T. Nkx2-1 represses a latent gastric differentiation program in lung adenocarcinoma. Mol. Cell 2013, Published online March 21, 2013. 10.1016/j.molcel.2013.02.018.
54. Travis W.D., Brambilla E., Noguchi M., Nicholson A.G., Geisinger K.R., Yatabe Y., Beer D.G., Powell C.A., Riely G.J., Van Schil P.E., et al. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J. Thorac. Oncol. 2011, 6:244-285.
55. Weir B.A., Woo M.S., Getz G., Perner S., Ding L., Beroukhim R., Lin W.M., Province M.A., Kraja A., Johnson L.A., et al. Characterizing the cancer genome in lung adenocarcinoma. Nature 2007, 450:893-898.
56. Weis S., Cui J., Barnes L., Cheresh D. Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation and metastasis. J. Cell Biol. 2004, 167:223-229.
57. Whitsett J.A., Haitchi H.M., Maeda Y. Intersections between pulmonary development and disease. Am. J. Respir. Crit. Care Med. 2011, 184:401-406.
58. Wilkerson M.D., Yin X., Walter V., Zhao N., Cabanski C.R., Hayward M.C., Miller C.R., Socinski M.A., Parsons A.M., Thorne L.B., et al. Differential pathogenesis of lung adenocarcinoma subtypes involving sequence mutations, copy number, chromosomal instability, and methylation. PLoS ONE 2012, 7:e36530.
59. Winslow M.M., Dayton T.L., Verhaak R.G., Kim-Kiselak C., Snyder E.L., Feldser D.M., Hubbard D.D., DuPage M.J., Whittaker C.A., Hoersch S., et al. Suppression of lung adenocarcinoma progression by Nkx2-1. Nature 2011, 473:101-104.
60. Wojcik S.M., Bundman D.S., Roop D.R. Delayed wound healing in keratin 6a knockout mice. Mol. Cell. Biol. 2000, 20:5248-5255.
61. Wong D.J., Liu H., Ridky T.W., Cassarino D., Segal E., Chang H.Y. Module map of stem cell genes guides creation of epithelial cancer stem cells. Cell Stem Cell 2008, 2:333-344.
62. Xu Y., Zhang M., Wang Y., Kadambi P., Dave V., Lu L.J., Whitsett J.A. A systems approach to mapping transcriptional networks controlling surfactant homeostasis. BMC Genomics 2010, 11:451.
63. Xu X., Rock J.R., Lu Y., Futtner C., Schwab B., Guinney J., Hogan B.L., Onaitis M.W. Evidence for type II cells as cells of origin of K-Ras-induced distal lung adenocarcinoma. Proc. Natl. Acad. Sci. USA 2012, 109:4910-4915.
64. Yang H., Lu M.M., Zhang L., Whitsett J.A., Morrisey E.E. GATA6 regulates differentiation of distal lung epithelium. Development 2002, 129:2233-2246.
65. Yang Y., Ahn Y.H., Gibbons D.L., Zang Y., Lin W., Thilaganathan N., Alvarez C.A., Moreira D.C., Creighton C.J., Gregory P.A., et al. The Notch ligand Jagged2 promotes lung adenocarcinoma metastasis through a miR-200-dependent pathway in mice. J. Clin. Invest. 2011, 121:1373-1385.
66. Yin Z., Gonzales L., Kolla V., Rath N., Zhang Y., Lu M.M., Kimura S., Ballard P.L., Beers M.F., Epstein J.A., Morrisey E.E. Hop functions downstream of Nkx2.1 and GATA6 to mediate HDAC-dependent negative regulation of pulmonary gene expression. Am. J. Physiol. Lung Cell. Mol. Physiol. 2006, 291:L191-L199.
67. Zhang Y., Rath N., Hannenhalli S., Wang Z., Cappola T., Kimura S., Atochina-Vasserman E., Lu M.M., Beers M.F., Morrisey E.E. GATA and Nkx factors synergistically regulate tissue-specific gene expression and development invivo. Development 2007, 134:189-198.
68. Zhang Y., Goss A.M., Cohen E.D., Kadzik R., Lepore J.J., Muthukumaraswamy K., Yang J., DeMayo F.J., Whitsett J.A., Parmacek M.S., Morrisey E.E. A Gata6-Wnt pathway required for epithelial stem cell development and airway regeneration. Nat. Genet. 2008, 40:862-870.